Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
For people whose goal is looking better and feeling stronger rather than hitting a specific number on the scale, this distinction matters
The incremental number of QALYs associated with SGLT2i use was projected at 29,357, and widespread use of SGLT2is was projected to lead to an incremental healthcare cost of AU$0.3 billion, resulting in an ICER of AU$8878 per QALY gained
124 ThomasK
Carnitine palmitoyl transferase-1A (CPTIA): a new tumor specific target in human breast cancer
(10) observed that CRP levels significantly increased in both the control and UA-supplemented groups compared to baseline among resistance-trained individuals, likely due to incomplete recovery during the 8-week training intervention, which may have led to persistent low-grade inflammation
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
